deaths from semaglutide Recent study at UC Irvine found that medication may benefit 93 million U.S. adults The letter cited three deaths

Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist T2DM: Type-2 diabetes mellitus DPP-4: Dipeptidyl peptidase 4 HbA1c: Hemoglobin A1c NASH: Non-alcoholic steatohepatitis NAFLD: Non-alcoholic fatty liver disease Camp: Cyclic adenosine monophosphate PKA: Protein kinase A EPAC: Exchange protein directly activated by cAMP PI3K: Phosphoinositide 3-kinase PYY: Peptide YY CCK: Cholecystokinin GLUT4: Glucose transporter type 4 mTORC1: Mammalian target of rapamycin complex 1 References Ahrn B (2015) Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes

Oral semaglutide (Rybelsus) It is the first oral FDA-approved GLP-1 receptor agonist that maintains low blood sugar for patients with type 2 diabetes in combination with diet and exercise

Semaglutide (The Single Agonist) Explained Semaglutide is a single GLP-1 agonist

As a licensed psychotherapist, behavior change specialist, and expert in the neuroscience of lasting transformation